Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01369459 · ClinicalTrials.gov registry record · Phase 1

Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder

A Phase 1 study of Attention Deficit Hyperactivity Disorder and Attention Deficit Disorder, sponsored by The National Center on Addiction and Substance Abuse at Columbia University.

Completed
Registry status
Phase 1
Development phase
14
Enrollment target
1
Study location

NCT01369459 is a Phase 1 study of Attention Deficit Hyperactivity Disorder and Attention Deficit Disorder that has completed, run by The National Center on Addiction and Substance Abuse at Columbia University. The registered enrollment target is 14 participants, below the 207-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01369459, a Phase 1 study of Attention Deficit Hyperactivity Disorder and Attention Deficit Disorder, has completed, sponsored by The National Center on Addiction and Substance Abuse at Columbia University.

COMPLETED
Registry status
Phase 1
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The goal of this project is to develop and test a brief protocol designed to systematically integrate pharmacological interventions for Attention Deficit Hyperactivity Disorder (ADHD) into behavioral treatment services for adolescent substance users with co-morbid ADHD in everyday care. Primary study aims will yield proof-of-concept data on MIP feasibility and fidelity in usual care and evidence of MIP impact on psychiatric and behavioral services utilization, medication acceptance and compliance, and satisfaction with treatment services.

Conditions Studied

Attention Deficit Hyperactivity Disorder Attention Deficit Disorder

Interventions

  • BEHAVIORAL MIP Protocol

Study Locations (1)

New York

  • Roberto Clemente Center - New York

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2011-11
Est. Completion 2014-12
Phase Phase 1

Sponsor

The National Center on Addiction and Substance Abuse at Columbia University

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01369459

The ClinicalTrials.gov registry entry for NCT01369459 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 207-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (93% lower). The listed sponsor is The National Center on Addiction and Substance Abuse at Columbia University, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which MIP Protocol is the first listed.

NCT01369459 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01369459 about?

NCT01369459 is a clinical study titled "Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder". The goal of this project is to develop and test a brief protocol designed to systematically integrate pharmacological interventions for Attention Deficit Hyperactivity Disorder (ADHD) into behavioral treatment services for adolescent substance users with co-morbid ADHD in everyday care. Primary stud...

What is the current status of trial NCT01369459?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2011-11. Estimated completion is 2014-12.

What conditions does trial NCT01369459 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder.

What interventions are being tested in trial NCT01369459?

The interventions under investigation include: MIP Protocol (BEHAVIORAL).

Who is sponsoring clinical trial NCT01369459?

This trial is sponsored by The National Center on Addiction and Substance Abuse at Columbia University, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01369459 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Attention Deficit Hyperactivity Disorder

All registered trials for this condition

Attention Deficit Disorder

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.